Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
crispr
4
×
detroit blog main
detroit top stories
gene editing
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
fda
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
ipo
biogen
car-t
clinical study
commissioner
congress
democrats
What
bio
roundup
crispr
moves
new
allogene
becker
big
billions
biopharma
bosley's
bosley’s
bridge
bucks
cancer
cas
ceo
congress
congressional
crime
departure
diversity
dollars
eaton
editas
executives
exit
feud
gene
group
guiding
healthcare
hot
immunotherapy
impact
investors
ipo
isn’t
juno
katrine
Language
Current search:
crispr
×
" gene editing "
×
" seattle top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More